Literature DB >> 35880229

Bacillus cereus meningoencephalitis in an immunocompetent patient.

Pichaya Tao Worapongsatitaya1, Jakrapun Pupaibool2.   

Abstract

Central nervous system (CNS) infection from Bacillus cereus (B. cereus) is rare and usually occurs in immunosuppressed patients or in a presence of invasive CNS devices. Our case reported here is a very rare case of an immunocompetent elderly patient without any CNS devices who was diagnosed with B. cereus meningoencephalitis and bacteremia. According to our patient, preceding gastrointestinal (GI) symptoms and trans-sphenoidal hypophysectomy could be the precipitating factors. A positive blood culture should not be concluded as a contamination but prompt repeating another set of blood culture for a better clinical judgment. Given its abrupt clinical course and high mortality rate, high index of suspicion for rapid detection and management is needed for a preferable clinical outcome. Empiric treatment with intravenous vancomycin is reasonable before a susceptibility result becomes available.
© 2022 The Authors.

Entities:  

Keywords:  Bacillus cereus; Central nervous system infection; Encephalitis; Meningitis; Meningoencephalitis

Year:  2022        PMID: 35880229      PMCID: PMC9307947          DOI: 10.1016/j.idcr.2022.e01577

Source DB:  PubMed          Journal:  IDCases        ISSN: 2214-2509


Background

Bacillus cereus (B. cereus) is facultatively anaerobic, spore-forming, Gram-positive, rod-shaped bacteria that present in the environment. It is one of the most common causes of food poisoning but infrequently can result in invasive extra-intestinal infections such as wound, eye, and respiratory tract infection [1], [2], [3]. It can also cause systemic infections including bacteremia and endocarditis [4], [5]. Central nervous system (CNS) infection from B. cereus is rare and usually associated with invasive CNS devices or immunosuppressed status. Herein, we report a case of an elderly patient without any invasive CNS devices or immunosuppressive agents who was diagnosed with B. cereus meningoencephalitis and bacteremia.

Case presentation

An 80-year-old patient with history of irritable bowel syndrome (IBS) and secondary adrenal insufficiency resulting from trans-sphenoidal hypophysectomy of a pituitary tumor eight years ago was re-admitted to the hospital with an acute onset of altered mental status and high-grade fevers 12 hours after being recently discharged from the previous hospitalization. The patient was previously hospitalized for four days with fatigue, abdominal pain, diarrhea, nausea, and vomiting, which were attributed to acute adrenal insufficiency resulting from poor compliance to corticosteroid treatment. During the past two years, the patient was admitted several times with the same diagnosis and clinical presentations. The patient’s medications included daily 20-milligram hydrocortisone and aspirin. The patient was originally from Mexico and moved to the United States 20 years ago. The patient denied using tobacco products, ethanol, and recreational drugs. There were no recent history of travel, sick contact, animal contact, and recent consumption of deli meats or unpasteurized dairy products. The patient was afebrile, however, the emergency room provider thought that this could be early symptoms and signs of sepsis, thus blood cultures were obtained and they did not grow any organisms. All symptoms improved after correction of hyponatremia and administration of systemic corticosteroid. The patient was feeling well before being discharged. The patient presented to the emergency department 12 hours later. On examination, the temperature was 40 °C, the pulse rate 108 per minute, the blood pressure 131/78 mmHg, the respiratory rate 13 breaths per minute, and the oxygen saturation 99% while the patient was breathing on ambient air. The patient appeared confused and would not answer questions or follow commands. Complete neurological assessment was difficult to perform due to altered mental status, however, only rigid neck was observed and the patient was able to move all extremities. The rest of the exam was otherwise unremarkable. Blood tests showed leukocytosis with white blood cell (WBC) count of 16,990 cells/µL with polymorphonuclear cells (PMN) of 87.5%. Meningoencephalitis was suspected, thus empirical antimicrobial therapy with vancomycin, cefepime, ampicillin, and acyclovir was initiated. The computed tomography (CT) of the head without contrast and CT angiography of the head and neck revealed no evidence of acute intracranial pathology. Unfortunately, given the presence of a pacemaker, a magnetic resonance imaging (MRI) of the brain could not be performed for further information. Lumbar puncture was performed and the cerebrospinal fluid (CSF) analysis revealed WBC of 1317 cells/µL (86% neutrophils, 10% monocytes, and 3% lymphocytes), protein of 496 mg/dL, and glucose of less than 5 mg/dL; the result was consistent with a bacterial infection. Gram stain of the CSF showed no organisms. CSF polymerase chain reaction (PCR) did not detect any of the following pathogens: Escherichia coli K1, Haemophilus influenzae, Listeria monocytogenes, Neisseria meningitidis, Streptococcus agalactiae, Streptococcus pneumoniae, cytomegalovirus (CMV), enterovirus, herpes simplex virus (HSV) type 1 and 2, varicella zoster virus (VZV), human herpesvirus (HHV) type 6, human parechovirus, and Cryptococcus neoformans/gatti. The antimicrobial regimen was de-escalated to intravenous ceftriaxone 2 g every 12 h. Bacterial and mycobacterial cultures from the CSF were negative. Two sets of blood cultures were obtained on two consecutive days of hospitalization due to no clinical improvement after initiation of intravenous antibiotics. One out of two blood culture bottles drawn on admission and a day after admission grew Bacillus cereus. Given the fact that there were two positive blood cultures, it was considered the most likely etiology of meningoencephalitis in this patient. Transthoracic echocardiogram did not reveal any vegetations of the native valves and pace maker leads. Intravenous vancomycin 0.75 g (adjusted dose) every 12 h was added. The CSF was subsequently sent for broad-range 16s rDNA PCR for definitive diagnosis. B. cereus was only susceptible to vancomycin and gentamicin, thus ceftriaxone was discontinued. The patient was treated with intravenous vancomycin for a total of 14 days without any adverse reactions. The patient had complete resolution of all the symptoms and subsequently was discharged nine days after the presentation. The result of the broad-range 16s rDNA PCR of the CSF came back positive for B. cereus confirming the diagnosis of CNS infection.

Methods

Our literature review of B. cereus was based on PubMed database. English keywords were used. The first search term "Bacillus cereus meningoencephalitis" yielded 7 articles (6 items are available in English). The second search term "Bacillus cereus meningitis" yielded 22 articles (17 items are available English). The abstracts of the articles retrieved from all two searches were reviewed, and the references from pertinent articles were reviewed to identify additional case reports. A total of 31 relevant publications were identified and the full articles on 41 patients with CNS infection from B. cereus were available for review.

Discussion and conclusions

Bacillus cereus is a Gram-positive, facultatively anaerobic, spore-forming bacilli which is widespread in the environment especially in soil or dust. Consequently, the contamination of this organism in hospital environment is inevitable. Study from Barrie et al. [6] showed association between B. cereus infection in patients and contamination of the organism in hospital environment. It can usually cause self-limited toxin-mediated gastrointestinal (GI) disease but the incidence of serious extra-intestinal infections has been increasingly reported according to previous published studies [7]. CNS infection with B. cereus is infrequent. It can present with various manifestations including ventriculitis, meningitis, meningoencephalitis, brain abscess, hydrocephalus, intraparenchymal, subarachnoid, and subdural hemorrhage (Table 1). The condition usually occurs in patients with defect in host defense mechanisms either from underlying primary or secondary immunodeficiency disorders, or invasive CNS procedures or devices. According to our literature review of the previous published adult and pediatric cases of B. cereus CNS infections (Table 1), chemotherapy may be associated with development of B. cereus CNS infections. Preterm delivery could also be one of the predisposing factors in pediatric patients [8]. To our knowledge, our case does not have an overt immunosuppressive condition. The daily dose of glucocorticoid replacement therapy for adrenal insufficiency is 20 mg of hydrocortisone daily (equivalent to 5 mg of prednisolone or prednisone), which is considered a physiologic dose. However, we did not do extensive workups for immunodeficiency disorders in this case, and immune dysfunction occurs with age. Immunosenescence could be a risk factor for B. cereus bacteremia and CNS infections in our case. Provided that there is no comparable case in the literature, it is difficult to predict the potential risk factors in this case. However, Berke et al. [9] reported a case of postoperative B. cereus meningitis after trans-septal trans-sphenoidal excision with retained ventriculostomy tube in a 25-year-old patient. Our patient's history of trans-sphenoidal hypophysectomy was eight years ago, true correlation of the procedure with the development of meningoencephalitis in our patient is questionable. The source of the infection in our patient has not been elucidated. One of the possibilities could be from GI tract since the patient presented with diarrhea during the previous hospitalization. The diarrhea could either be from the underlying condition of IBS or from possible prior bacterial infection. A report by Gaur et al. [10] showed that in three out of four patients with B. cereus bacteremia, the organism was isolated in cultures of their stools or rectal swabs obtained within 72 h of presentation of the infection. However, it is still not clear if rectal colonization could be the source of the bacteremia. Contaminated intravenous fluid during the previous admission could be another possible source of bacteremia in our patient.
Table 1

Summary of previously reported cases of Bacillus cereus CNS infection.

YearAuthor [ref]Clinical diagnosisAge/SexOutcomesPredisposing conditionsTreatments
1970Leffert et al. [14]Meningitis18 weeks /Mrecovered

Dandy-Walker cyst

Ventriculo-arterial shunt revision

Ampicillin

Gentamicin

1977Turnbull et al. [15]Encephalitis with extensive necrosis of brain1 day /Fdied

Preterm delivery

Necrotizing enterocolitis

Umbilical catheter

Ampicillin

Gentamicin

1981Colpin et al. [16]Meningitis19 years /Mdied

Post chemotherapy

Granulopenia

Central line

Penicillin

Gentamicin

1981Berke et al. [9]Ventriculitis and meningitis25 years /Frecovered

Ventriculostomy

Trans-septal trans-sphenoidal excision of pituitary adenoma

Chloramphenicol

Vancomycin

1981Hendrickx et al. [17]Meningoencephalitis with complete hemorrhagic necrosis of the brain8 days /Fdied

Preterm delivery

Ventricular puncture

Central line

Ampicillin

Gentamicin

Erythromycin

1984Garcia et al. [18]Leptomeningitis32 years /Mrecovered

Ommaya reservoir

Penicillin

Chloramphenicol

1988Feder et al. [19]Meningitis47 days /Frecovered

Preterm delivery

Central line

Ampicillin

Chloramphenicol

1989Jenson et al. [20]Cerebritis, hemorrhagic necrosis, meningitis3 years /Mrecovered

Post chemotherapy + intrathecal methotrexate

Immunosuppression

Severe neutropenia

Chloramphenicol

Vancomycin

Gentamicin

Rifampin

1991Weisse et al. [21]MeningitisMeningitis5 days /M24 days /Mrecoveredrecovered

Preterm delivery

Myelomeningocele sac rupture

None

Ampicillin

CeftazidimeVancomycin

Gentamicin

Chloramphenicol

1992Barrie et al. [6]HydrocephalusCerebellar hematoma55 years /F41 years /Fdieddied

Ventricular drain

Post-operative course of acoustic neuroma

Ventricular drain

Post operative course of microdissection of trigeminal nerve

Vancomycin

Vancomycin

Chloramphenicol

1995Marley et al. [22]Meningoencephalitis, subarachnoid hemorrhage, liver and myocardium necrosis26 years /Mdied

Post chemotherapy

Immunosuppression

Severe neutropenia

Ceftazidime

1997Akiyama et al. [23]Leptomeningitis, subarachnoid hemorrhage, liver and stomach necrosis64 years /Mdied

Post chemotherapy

Immunosuppression

Central line

Piperacillin

Gentamicin

Cefoperazone

Cefotaxime

Ampicillin

1997Berner et al. [24]Meningitis18 months /Mrecovered

Ventriculo-peritoneal drain

Vancomycin

Fosfomycin

1999Tokieda et al. [8]Multiple brain parenchyma, subdural, epidural, subarachnoid hemorrhageWide spread softening and hemorrhagic necrosis of the brain4 days /F5 days /Fdieddied

Hydrop fetalis

Unknown

Ampicillin

Gentamicin

Ampicillin

Cefotaxime

1999Musa et al. [25]Leptomeningeal and neural necrosis30 years /M43 years /M14 years /Mdieddieddied

Severe neutropenia

Central line

Severe neutropenia

Post chemotherapy

Neutropenia

Ceftazidime

Amikacin

Ceftazidime

Amikacin

Ceftazidime

Amikacin

2000Tuladhar et al. [26]Intraventricular hemorrhage14 days /Mdied

Preterm delivery

Vancomycin

Gentamicin

Imipenem

Clindamycin

Ciprofloxacin

2000Marshman et al. [27]Fulminant meningitis41 years /Frecovered

Anterior fossa repair

Spinal drainage

Teicoplanin

Gentamicin

Ciprofloxacin

Erythromycin

2001Gaur et al. [10]Right basal ganglia infarctionMeningoencephalitisMeningoencephalitis, hydrocephalusMultiple brain abscess concern for septic emboli20 years /F15 years /F13 years /F10 years /Fdieddiedsurvived with severe sequelesurvived with mild sequele

Intrathecal chemotherapy

Neutropenia

Central line

Vancomycin

2001Chu et al. [28]Meningitis with liquefactive necrosis of the brain30 days /Mdied

Preterm delivery

Bronchopulmonary dysplasia

Dexamethasone use

Vancomycin

Amikacin

2003de Almeida et al. [29]Meningitis16 years /Fdied

Post bone marrow transplant

Immunosuppression

Ceftazidime

Imipenem

2004Heep et al. [30]Ventriculitis, hemorrhagic necrotizing lesion14 days /Mnot reported

Ventriculostomy tube

Vancomycin

Gentamicin

Meropenem

2005Haase et al. [31]Meningoencephalitis, flaccid hemiparesis19 years /Mrecovered

During chemotherapy

Central line

Ceftazidime

Teicoplanin

Ampicillin

Amikacin

Ciprofloxacin

Clindamycin

2005Lequin et al. [32]MeningoencephalitisMeningoencephalitisMeningoencephalitis, ventriculitis5 days /F5 days /F13 days /Fdieddieddied

Preterm delivery

Preterm delivery

Respiratory distress syndrome

Preterm delivery

Central line

Amoxicillin

Cefotaxime

Vancomycin

Amikacin

Vancomycin

Amikacin

Amoxicillin

Cefotaxime

Vancomycin

Clindamycin

2008Manickam N et al. [33]Meningoencephalitis with hemorrhagic necrosis and liquefaction of brain tissue8 days /Mdied

Preterm delivery

Ampicillin

Gentamicin

Vancomycin

Cefotaxime

Acyclovir

2009Lebessi et al. [34]Meningitis3 days /Mrecovered

Unknown

Ampicillin

Vancomycin

Netilmicin

2010Drazin et al. [35]Meningoencephalitis with brain abscess7 days /Frecovered

Preterm delivery

Vancomycin

Amikacin

Gentamicin

Meropenem

2012Horii et al. [36]Meningitis2 months /Frecovered

Preterm delivery

Prior blood stream infection

Meropenem

Clindamycin

Linezolid

2012Stevens et al. [11]Meningitis73 years /Frecovered

Ommaya reservoir

Intrathecal methotrexate and hydrocortisone

Vancomycin

Cefepime

2013Tatara et al. [37]Meningoencephalitis and septicemia60 years /Mrecovered

Myelodysplastic syndrome

Pancytopenia

Vancomycin

Ciprofloxacin

Micafungin

2020Koizumi Y et al. [38]Meningitis and bacteremia54 years /Frecovered

During chemotherapy

Leukocytopenia

Meropenem

Vancomycin

Linezolid

Acyclovir

aTreatment refers to antimicrobial therapy for the whole duration of illness.

Summary of previously reported cases of Bacillus cereus CNS infection. Dandy-Walker cyst Ventriculo-arterial shunt revision Ampicillin Gentamicin Preterm delivery Necrotizing enterocolitis Umbilical catheter Ampicillin Gentamicin Post chemotherapy Granulopenia Central line Penicillin Gentamicin Ventriculostomy Trans-septal trans-sphenoidal excision of pituitary adenoma Chloramphenicol Vancomycin Preterm delivery Ventricular puncture Central line Ampicillin Gentamicin Erythromycin Ommaya reservoir Penicillin Chloramphenicol Preterm delivery Central line Ampicillin Chloramphenicol Post chemotherapy + intrathecal methotrexate Immunosuppression Severe neutropenia Chloramphenicol Vancomycin Gentamicin Rifampin Preterm delivery Myelomeningocele sac rupture None Ampicillin CeftazidimeVancomycin Gentamicin Chloramphenicol Ventricular drain Post-operative course of acoustic neuroma Ventricular drain Post operative course of microdissection of trigeminal nerve Vancomycin Vancomycin Chloramphenicol Post chemotherapy Immunosuppression Severe neutropenia Ceftazidime Post chemotherapy Immunosuppression Central line Piperacillin Gentamicin Cefoperazone Cefotaxime Ampicillin Ventriculo-peritoneal drain Vancomycin Fosfomycin Hydrop fetalis Unknown Ampicillin Gentamicin Ampicillin Cefotaxime Severe neutropenia Central line Severe neutropenia Post chemotherapy Neutropenia Ceftazidime Amikacin Ceftazidime Amikacin Ceftazidime Amikacin Preterm delivery Vancomycin Gentamicin Imipenem Clindamycin Ciprofloxacin Anterior fossa repair Spinal drainage Teicoplanin Gentamicin Ciprofloxacin Erythromycin Intrathecal chemotherapy Neutropenia Central line Vancomycin Preterm delivery Bronchopulmonary dysplasia Dexamethasone use Vancomycin Amikacin Post bone marrow transplant Immunosuppression Ceftazidime Imipenem Ventriculostomy tube Vancomycin Gentamicin Meropenem During chemotherapy Ceftazidime Teicoplanin Ampicillin Amikacin Ciprofloxacin Clindamycin Preterm delivery Preterm delivery Respiratory distress syndrome Preterm delivery Central line Amoxicillin Cefotaxime Vancomycin Amikacin Vancomycin Amikacin Amoxicillin Cefotaxime Vancomycin Clindamycin Preterm delivery Ampicillin Gentamicin Vancomycin Cefotaxime Acyclovir Unknown Ampicillin Vancomycin Netilmicin Preterm delivery Vancomycin Amikacin Gentamicin Meropenem Preterm delivery Prior blood stream infection Meropenem Clindamycin Linezolid Ommaya reservoir Intrathecal methotrexate and hydrocortisone Vancomycin Cefepime Myelodysplastic syndrome Pancytopenia Vancomycin Ciprofloxacin Micafungin During chemotherapy Leukocytopenia Meropenem Vancomycin Linezolid Acyclovir aTreatment refers to antimicrobial therapy for the whole duration of illness. Given its ubiquitous presence, the isolation of B. cereus from sterile clinical specimens is usually considered as a contamination, especially in immunocompetent patients. The positive blood culture for B. cereus in our patient was initially interpreted as a contamination considering the patient’s immune status, an absence of invasive CNS devices, and a report of one positive blood culture out of the two bottles on the first day. However, one positive bottle for two consecutive days had pointed the positive blood cultures towards being from a true pathogen. Subsequently, the positive broad-range 16s rDNA PCR from the CSF for B. cereus confirmed the diagnosis. B. cereus CNS infection usually has an abrupt clinical course and a high mortality rate despite aggressive treatment with broad-spectrum antimicrobial therapy. High index of suspicion is needed for rapid detection and management [11]. To date, there is still no standard guideline of treatment for B. cereus CNS infection, thus guidance on management comes solely from previously reported cases. The production of beta-lactamases makes B. cereus resistant to beta-lactam antimicrobial agents including third-generation cephalosporins but the organism is known to be susceptible to aminoglycosides, clindamycin, erythromycin, vancomycin, and chloramphenicol [7]. Vancomycin is generally considered the preferred agent for empiric therapy and was used in many reported cases including in our patient [12]. On the other hand, due to the outright and inducible resistance of B. cereus against clindamycin, the agent should not be used before the susceptibility results become available [13]. In our case, after the susceptibility report showed susceptibility to vancomycin, the treatment with intravenous vancomycin monotherapy for 14 days resulted in complete resolution of the clinical symptoms. The patient felt lucky that the condition was diagnosed correctly and that the patient got better with the treatment received. This presenting case adds new learning points to the body of literature on B. cereus CNS infection. We believe that B. cereus should be included in one of the differential pathogens causing CNS infections in patients who had preceding GI signs and symptoms and with a history of trans-sphenoidal hypophysectomy regardless of duration after the procedure. A positive blood culture of B. cereus in one out of two obtained bottles should not be concluded as a contamination but prompt repeat another set of blood cultures for a better clinical judgment. The empiric treatment with intravenous vancomycin is reasonable before a susceptibility result becomes available.

Ethics approval

Not applicable.

Consent

Written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Funding

There were no sources of funding used in data collection, the preparation, and the submission of this manuscript. This case report did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author’s contributions

The manuscript was read and approved by all the authors. Pichaya Tao Worapngsatitaya: writing original draft. Jakrapun Pupaibool: reviewing, editing, and supervising. All authors contributed to the work in this manuscript.

CRediT authorship contribution statement

Pichaya Tao Worapngsatitaya: writing-original draft preparation, software, investigation, Jakrapun Pupaibool: conceptualization, methodology, software, validation, writing, reviewing, editing, supervision, All authors contributed to the work in this manuscript.

Conflicts of interests

The authors have no conflicts of interests to declare.
  38 in total

1.  Bacillus cereus meningitis in a patient under gnotobiotic care.

Authors:  G G Colpin; H F Guiot; R F Simonis; F E Zwaan
Journal:  Lancet       Date:  1981-09-26       Impact factor: 79.321

2.  Meningitis and bacteremia after ventriculoatrial shunt-revision: isolation of a lecithinase-producing Bacillus cereus.

Authors:  H L Leffert; J N Baptist; L I Gidez
Journal:  J Infect Dis       Date:  1970-12       Impact factor: 5.226

3.  Successful treatment of Bacillus cereus meningitis following allogenic stem cell transplantation.

Authors:  Roland Haase; Harald Sauer; Urantschimeg Dagwadordsch; Jürgen Foell; Ulla Lieser
Journal:  Pediatr Transplant       Date:  2005-06

Review 4.  Neonatal meningoencephalitis caused by Bacillus cereus.

Authors:  Nisha Manickam; Aimee Knorr; Kenneth L Muldrew
Journal:  Pediatr Infect Dis J       Date:  2008-09       Impact factor: 2.129

5.  Meningitis due to Bacillus cereus: A case report and review of the literature.

Authors:  Michael P Stevens; Kara Elam; Gonzalo Bearman
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

6.  Endophthalmitis caused by Bacillus species.

Authors:  John J Miller; Ingrid U Scott; Harry W Flynn; William E Smiddy; Timothy G Murray; Audina Berrocal; Darlene Miller
Journal:  Am J Ophthalmol       Date:  2008-03-04       Impact factor: 5.258

7.  Fulminant postsurgical Bacillus cereus meningitis: case report.

Authors:  E Berke; W F Collins; A von Graevenitz; F J Bia
Journal:  J Neurosurg       Date:  1981-10       Impact factor: 5.115

8.  Fatal Bacillus cereus meningoencephalitis in an adult with acute myelogenous leukemia.

Authors:  E F Marley; N K Saini; C Venkatraman; J M Orenstein
Journal:  South Med J       Date:  1995-09       Impact factor: 0.954

9.  Susceptibility of Bacillus anthracis, Bacillus cereus, Bacillus mycoides, Bacillus pseudomycoides and Bacillus thuringiensis to 24 antimicrobials using Sensititre automated microbroth dilution and Etest agar gradient diffusion methods.

Authors:  Vicki A Luna; Debra S King; Jenny Gulledge; Andrew C Cannons; Philip T Amuso; Jacqueline Cattani
Journal:  J Antimicrob Chemother       Date:  2007-06-22       Impact factor: 5.790

10.  Bacillus cereus Bloodstream Infection in a Preterm Neonate Complicated by Late Meningitis.

Authors:  Toshinobu Horii; Kiyoko Tamai; Shigeyuki Notake; Hideji Yanagisawa
Journal:  Case Rep Infect Dis       Date:  2012-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.